Case Author: Dr Brian HarnettCase Reviewer: Dr Donald ArnoldLearning Objectives:At the end of this self-assessment module, participants should be able to:Determine appropriate use of thrombopoietin receptor agonists in the setting of immune thrombocytopenia (ITP) and chronic liver disease. Determine clinical settings where certain thrombopoietin...
Author: Dr. Pallavi Ganguli, MDCM, Queen’s UniversityReviewer: Dr. Eugenia Piliotis, MD, MPH, Associate Dean, Queen’s University, Kingston General HospitalLearning objectives:At the end of this self-assessment module, participants should be able to:Understand the presentation of Mycosis fungoides Review appropriate investigations for the diagnosis of Mycosis...
Author: Dr. Stefan Jevtic (McMaster University) and Dr. Danyal Ladha (University of Toronto)Reviewer: Dr. Natasha Rupani, University of Toronto Learning Objectives At the end of the self-assessment module, learners will be able to: 1) Describe an approach to the diagnosis of heparin-induced thrombocytopenia 2) Identify risk factors and clinical...
Author: Dr. Yaqeen Abduallah, University of Manitoba Reviewer: Dr. Roopesh KansaraLearning ObjectivesAs the end of this self-assessment module, participants should be able to: 1. Describe the treatment options for patients with relapsed/refractory DLBCL 2. Described the mechanism of action of polatuzumab 3. Describe the most common adverse reactions of...
April 25, 2023 live presentation date...
Author: Dr. Aneesh Thakore, Dr. Danyal Ladha, University of TorontoReviewer: Dr. Hassan Sibai, Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer CentreLearning Objectives:As the end of this self-assessment module, participants should...
Author: Dr. Pallavi Ganguli PGY-4 Hematology, Queen’s University Reviewer: Dr. Robert Kridel, MD, MPH, PhD, Clinician Scientist, Princess Margaret Cancer CentreLearning Objectives:As the end of this self-assessment module, participants should be able to:1. Describe novel therapies for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) in...
Author: Dr. Barbara Gunka, McMaster UniversityReviewers: Dr. Danyal Ladha and Dr. Irwin Walker Learning Objectives: At the end of the self-assessment module, participants will be able to:Understand the presentation of non-Langerhans-cell histiocytosis Review diagnostic modalities and challenges Understand treatment options in Erdheim-Chester DiseaseScientific Planning Committee Dr. Danyal...
Authors: Dr. Anath Lionel and Dr. Joanne Britto, McMaster UniversityReviewer: Dr. Hassan Sibai, Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer CentreLearning Objectives:As the end of this self-assessment module, participants should...